VITROLIFE A/S: Financial statements 2022
CVR: 27406793
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
VITROLIFE A/S (CVR 27406793) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 219,325,000 and a net result of DKK 107,758,000 compared with DKK 96,519,013 the year before. That is an increase of 13% compared with the year before. Equity in the 2022 report amounted to DKK 255,754,000. The solvency ratio was 86.4%. The company had 90 employees in the financial year.
- Gross Profit
- DKK 219,325,000
- Profit/Loss
- DKK 107,758,000
- Equity
- DKK 255,754,000
- Total Assets
- DKK 295,855,064
- Employees
- 90
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 219.3M | 107.8M | 255.8M | 90 |
| 2021 | - | 194.2M | 96.5M | 247.5M | 86 |
| 2020 | - | 130.4M | 57.3M | 210.6M | 82 |
| 2019 | - | 183M | 94.3M | 153.2M | 81 |
| 2018 | - | 145.2M | 68.3M | 58.9M | 77 |
Official annual report
Keep an eye on VITROLIFE A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
VITROLIFE A/S has published its annual report for 2021. Gross profit came to DKK 194,178,750, and the net result was DKK 96,519,013.
As of January 10, 2022, Tony Patrik Tolf has joined the board of directors of VITROLIFE A/S.
As of January 10, 2022, Bo Lars Risberg has joined the board of directors of VITROLIFE A/S.
As of January 10, 2022, Erik Mikael Engblom has left the board of directors of VITROLIFE A/S.
About VITROLIFE A/S
VITROLIFE A/S is a Danish company of the type Aktieselskab based in Viby J, founded in 2003. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named UNISENSE FERTILITECH A/S and UNISENSE FERTILITECH ApS. The management consists of Dag Erik Rickard Ericsson. The board consists of Sten Jakob Hedén (chair), Dag Erik Rickard Ericsson and Tom Faes. The company is owned by Vitrolife AB. The company has 114 employees (2026). In 2025, the company reported a gross profit of DKK 228,406,323 and a net result of DKK 110,485,853 compared with DKK 130,285,262 the year before. Equity in the 2025 report amounted to DKK 327,839,900.